Pricing Log in Create free account

Arrowhead Pharmaceuticals, Inc. (ARWR) vs ImmunityBio, Inc. (IBRX)

Arrowhead Pharmaceuticals, Inc. and ImmunityBio, Inc. are both Biotechnology companies. Arrowhead Pharmaceuticals, Inc. and ImmunityBio, Inc. are of similar size ($8.5B and $8.1B). ImmunityBio, Inc. grew revenue faster over the last twelve months: 192.9% against 16.1%. Arrowhead Pharmaceuticals, Inc. has the higher net margin (−47.8% vs −598.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Arrowhead Pharmaceuticals, Inc. leads on 12 and ImmunityBio, Inc. on 4.

Valuation

Metric ARWR IBRX Biotechnology median
P/E n/m n/m 10.60
P/S 12.42 54.91 9.40
P/B 17.85 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 11.32 60.33 9.02
Earnings yield (3.88%) (11.19%) (32.88%)
Free cash flow yield (0.90%) (3.16%) (23.13%)

Profitability

Metric ARWR IBRX Biotechnology median
Gross margin 100.00% 99.34% 68.51%
Operating margin (33.82%) (151.88%) 0.00%
Net margin (47.79%) (598.56%) 0.00%
Free cash flow margin (11.22%) (173.76%) 0.00%
Return on equity (64.91%) 122.85% (51.96%)
Return on assets (18.32%) (192.58%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ARWR IBRX Biotechnology median
Revenue growth (TTM) 16.13% 192.92% 6.76%
EPS growth (last fiscal year) 99.80% 38.71% 29.88%
Revenue growth, 5-year CAGR 56.63% 184.76% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARWR IBRX Biotechnology median
Debt to equity 1.85 (0.74) 0.00
Current ratio 5.90 5.72 4.97
Net debt to EBITDA (5.70) (0.97) 1.01

Dividend

Metric ARWR IBRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ARWR IBRX Biotechnology median
Market cap 8.12b 8.49b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack